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ABSTRACT 
The TPNH- and O~-dependent drug hydroxylation system of liver microsomes has been 
studied using normal rats and rats in which the drug-hydroxylating activity has been cn- 
hanccd by repeated injections of phenobarbital. The oxidative demcthylation of amino- 
pyrine is cmploycd as an assay.  Optimal conditions for  the assay with regard to the con- 
ccntrations of TPNH  and  aminopyrine are  established.  TPN inhibits the  reaction in a 
competitive manncr, similarly to  its  effect  on  the  microsomal TPNH-cytochrome c rc- 
ductase. Drug hydroxylation, but not the "TPNH oxidase," TPNH-cytochrome c, -2,6- 
dichlorophcnolindophcnol,  or -ncotctrazolium rcductase reaction, or the TPNH-dcpcndcnt 
lipid peroxidation, is blocked by carbon monoxide. Microsomes from phenobarbital-treated 
rats exhibit increased activities of the various TPNH-linked reductase reactions, parallel 
to the increased drug hydroxylation activity, whereas the "TPNH oxidasc"  activity does 
not change appreciably. Measurements with microsomcs from drug-treated animals reveal a 
1 : 1 : 1 stoichiometry of aminopyrine-dependent  oxygen uptake, TPNH oxidation,  and formal- 
dehydc formation. Attempts to solubilize the drug-hydroxylating enzyme system  are also 
presented. It is concluded that the drug-hydroxylating enzymc system involvcs the micro- 
somal TPNH~ytochrome c reductase and CO-binding pigment, and a hypothctic reaction 
scheme accounting for the data prcscntcd is proposcd. 
INTRODUCTION 
In a previous paper (I) it has been reported that 
rcpeatcd  administration of phenobarbital to  rats 
results in an increased activity of the drug-hydrox- 
ylating cnzymc system of liver microsomes.  The 
activation was parallelcd by selective  increases in 
the  activity  of  TPNHl-cytochrome  c  reductase 
1 Abbreviations  used  arc: DPN  and TPN,  di-  and 
triphosphopyridine  nucleotide,  oxidized  forms  ; 
DPNH  and TPNH, di- and triphosphopyridine  nu- 
cleotide,  reduced  form;  NT,  neotetrazolium chlo- 
ride; DCPIP, 2,6-dichlorophenolindophenol;  PCMB, 
p-chloromercuribenzoate;  SKF  525A, ~-diethyla- 
minoethyl-diphenylpropylacetate;  DPPD,  diphenyl- 
phenylenediamine;  DIC, dicoumarol; FA, formalde- 
(2--4) and the  amount of the hemoprotein called 
"CO-binding pigment"  (5)  or  "cytochrome  P- 
450"  (6,  7).  It was concluded (1)  that these two 
enzymes  probably constitute components of  the 
TPNtt-  and  O~-dependent  drug-hydroxylating 
system. 
In order to gain further insight into the nature 
and mechanism of this substrate-induced enzyme 
activation, it was thought desirable to investigate 
in some detail certain biochemical parameters of 
the  drug-hydroxylating  enzyme  system.  Con- 
hyde;  MA,  malonaldehyde; AP,  aminopyrine; PP, 
inorganic pyrophosphatc. 
713 versely, induction in vivo provided a  simple means 
of enriching the enzyme system in the microsomes, 
thus facilitating the study of its biochemical prop- 
erties. The present work was undertaken with both 
these goals in mind. The data reported here pro- 
vide  information  relating  to  the  kinetics  of  the 
reaction, its stoichiometry and dependence on sub- 
strate  concentration,  and  the  effects  of  various 
electron donors  and  acceptors and  of inhibitors, 
as well as attempts to solubilize the drug-hydroxyl- 
ating enzyme system, using liver microsomes from 
rats before or after treatment with phenobarbital. 
The results have been reported in  part in  a  pre- 
liminary form (8-11). 
MATERIALS  AND  M~TttODS 
Male  Sprague-Dawley  rats  (200  to  300  gin)  were 
starved overnight and killed by decapitation. Prepa- 
ration of microsomes was performed as described by 
Ernster et al.  (12).  In  the experiments with pheno- 
barbital-treated  rats  the  animals  were  given  daily 
intraperitoncal injections of 100 mg of phenobarbital 
per kg body weight. 
Oxidative dcmethylation activity of the microsomes 
was  assayed  with  aminopyrine  as  substrate.  The 
standard  incubation  system  contained  microsomcs 
(ca. 2 mg of protein), 5 mM aminopyrine, 0.05  M tris 
buffer  (pH  7.5),  50  mM nicotinamide, 5 mM MgCI2, 
0.5  mM TPN,  and  a  TPNH-generating system con- 
sisting of 5  mM  DL-isocitrate,  0.01 mM  MnCl~,  and 
enough isocitric dehydrogenase to reduce 0.32/zmole 
TPN per minute, in a final volume of 2 ml. The time 
of incubation was  20  minutes  and  the temperature 
37°C.  The reaction was stopped by  the  addition of 
0.25  ml  25  per  cent ZnSO4  and  0.25  ml  saturated 
Ba(OH)2.  The amount of formaldehyde formed was 
measured by the Nash reaction (13). 
Lipid  peroxidation activity was measured by  de- 
termining the amount of malonaldehyde formed with 
the thiobarbituric acid reaction (14).  The incubation 
system (15)  included microsomes, 0.025  M tris buffer 
(pH  7.5),  0.15  M KC1,  0.3  mM TPNH,  and Fe2+pp 
(12  /ZM Fe(NH4)2(SO4)2.6H20  and 0.2  mM NaPP), 
in a final volume of 2 ml.  Incubation was for 6 min- 
utes  at  37°C.  The  reaction was stopped with  2  ml 
30 per cent trichloroacetic acid. 
TPNH-cytochrome  c  reductase,  TPNH-DCPIP 
reductase,  and  TPNH-neotetrazolium  (NT)  reduc- 
tase activities and the content of CO-binding pigment 
were determined as described by Dalluer  (16). 
TPNH oxidase activity was assayed by measuring 
oxygen  consumption  with  a  Clark  electrode  in  a 
system  containing  microsomes  (ca.  5  mg  protein), 
0.05 M tris buffer (pH 7.5),  and 0.3  mM TPNH. The 
reaction was started by the addition of TPNH.  The 
temperature was 30°C. 
Experiments aiming at solubilization of the oxida- 
tive demethylation system were performed by incu- 
bating microsomes (10 to 15 mg protein per ml) in a 
medium containing 0.05  M tris buffer  (pH  9.0)  and 
0.1  per cent heat-treated (17) Naja naja venom aero- 
bically for 30 minutes at 30°C. After the incubation, 
pH  was  adjusted to  7.0,  a  procedure which largely 
prevents  the  further  action  of the  Naja  naja phos- 
pholipase. The suspension was centrifuged at 105,000 
g for 60 minutes.  2 The resulting supernatant, and the 
pellet resuspended in 0.25  M sucrose, were used for 
enzyme assays.  In order to avoid disturbance of the 
spectrophotometric  determination  of  CO-binding 
pigment  by  contaminating  hemoglobin,  the  livers 
used in these experiments were perfused in situ with 
ice cold 0.9 per cent NaC1  before homogenization. 
Protein was determined according to the method 
of Lowry et al.  (18). 
All chemicals  employed were standard commercial 
products. 
RESULTS 
Studies with Normal Rats 
Figs.  l  and 2 illustrate the rate of oxidative de- 
methylation of aminopyrine,  measured  by  deter- 
mining the amount of formaldehyde formed, as a 
function of the concentrations of aminopyrine and 
TPNH.  The Lineweaver-Burk plots (Figs.  lb  and 
2b) reveal _K~ (Michaelis constant) valuesof 8.0  X 
10-4M  for  aminopyrine  and  2.5  X  10-sM  for 
TPNH. When saturating concentrations of amino- 
pyrine and TPNH were used, the rate of the reac- 
tion was linear with time up to at least 50 minutes 
(Fig.  3 b),  and  with  the  amount  of  microsomal 
protein (Fig. 3 a). The maximal rate of oxidative 
demethylation  of  aminopyrine  was  2.5  to  3.5 
m/~moles  formaldehyde  formed  per  minute  per 
milligram protein. 
Under standard conditions, TPNH  was gener- 
ated  by  the isocitric dehydrogenase system. This 
was  preferred  to  the  glucose-6-phosphate dehy- 
drogenase system, in  view of the high glucose-6- 
phosphatase activity of the microsomes. The con- 
centration  of  Mn  ++,  which  is  an  activator  of 
isocitric  dehydrogenase,  was  kept  lower  than 
needed for maximal activation of the enzyme, since 
it was found that higher concentrations of Mn  ++ 
In order to make certain that  the supernatant did 
not  contain  any  poorly  sedimentable  particulate 
material,  experiments were performed in  which the 
time  of centrifugation  after  solubilization was  pro- 
longed up  to 4  hours  at  105,000  g.  This treatment, 
however, did not change the results. 
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FIGURE 1  Fig. 1 a, rate of oxidative demethylation of aminopyrine with varying concentrations of amino- 
pyrine. FA, formaldehyde. 
Fig. 1 b, Lineweaver-Burk plot of Fig. 1 a. [S] aminopyrine, raM; v, relative reaction velocity. 
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FIGURE 2  Fig.  2  a,  rate  of  oxidative demethylation  of  aminopyrine  with  varying concentrations  of 
TPNH. TPNH was generated by the isocitric dehydrogenase reaction (see Materials and Methods). 
Fig. ~ b, Lineweaver-Burk plot of oxidative demethylation of aminopyrine with varying concentrations 
of generated TPNH.  [S], TPNH, m~; v, relative reaction velocity. 
may depress  the  rate  of oxidative demethylation. 
It was  also found  essential  to  include  10  -2 M nic- 
otinamide  in  the  reaction  medium,  in  order  to 
prevent breakdown  of TPN by a  TPNase  present 
in  the  microsomes;  as  ascertained  in  complemen- 
tary  experiments,  this  enzyme  appears  to  attack 
only  the  oxidized,  and  not  the  reduced,  form  of 
TPN. 
TPN  inhibited  the  oxidative  demethylation  of 
aminopyrine.  In Fig.  4,  the rates of oxidative de- 
methylation  are compared  as measured  with var- 
ying  concentrations  of  added  (not  generated) 
TPNH  in  the  absence  and  presence  of nicotina- 
mide  and  of varying  concentrations  of TPN.  In 
the  absence  of  nicotinamide  and  TPN,  added 
TPNH  supported  the reaction with the same effi- 
ciency as did  generated  TPNH  (cf.  Figs.  2  a  and 
b  and  4 a).  The  presence of nicotinamide,  allow- 
ing  an  accumulation  of ~PN  from TPNH  in  the 
course  of the oxidative demethylafion,  caused  an 
apparent  elevation in  the  saturating  TPNH  con- 
centration,  which  could  be  increased  further  by 
added  TPN  (Fig.  4 a).  The  inhibition  by  TPN 
was  competitive  wilh  respect  to  TPNH  (Fig. 
4 b),  with  a  -Ki  (inhibitor  constant)  value  of 2.8 
j(  10-4 M. 
Replacement  of TPNI-I  by  DPNH  resulted  in 
low  rates  of oxidative  demethylation  (Table  I). 
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F~GURE 3  Fig. 3 a, rate of oxidative demethylation of aminopyrine with varying amounts of mierosomes. 
Fig. 3 b, amount of formaldehyde formed from the oxidative demethylation of aminopyrine as a func- 
tion of time of incubation. 
Combination  of TPNH  and  DPNH  did  not  in- 
crease  the  maximal  rate  obtained  with  TPNH 
alone. Addition of 0.5 to 1.0 mM TPN to the DPNH 
system  gave  rise  to  an  oxidative  demethylation, 
the rate of which was  approximately 40  per cent 
of that obtained with TPNH; decrease or increase 
of the TPN concentration  beyond this range low- 
ered the rate.  These results confirm earlier obser- 
vations  (19)  and  suggest  that  microsomes  may 
contain  a  transhydrogenase  by which TPNH  can 
be generated from DPNH. Also in accordance with 
previous  reports  (20),  ascorbate was found ineffi- 
cient as an electron donor for drug hydroxylation. 
In addition to drug hydroxylation and reduction 
of cytochrome c, rat liver microsomes are known to 
catalyze TPNH  oxidation linked to the reduction 
of  various  artificial  electron  acceptors  such  as 
DCPIP  (12,  16,  21)  and NT (3,  16,  22).  Further- 
more,  as  recently  shown  by  Hochstein  et  al.  (15, 
23, 24), TPNH is able to induce a  peroxidation of 
endogenous  microsomal  lipids  provided  that  a 
catalytic  amount  of FePP  is  added;  the  reaction 
can  be  followed  conveniently  by  measuring  the 
amount of malonaldehyde, which is a split product 
of lipid peroxides,  and which has been found  (23, 
24)  to be produced  during  microsomal lipid per- 
oxidation to an extent of approximately 5 per cent 
of the  total  oxygen  consumption.  Table  II  and 
• Fig.  5 compare these various microsomal TPNH- 
oxidizing activities with  regard  to  their  response 
to known inhibitors of microsomal drug hydroxyl- 
ation.  Carbon monoxide has been shown to block 
drug hydroxylation in liver microsomes (8),  anal- 
ogously  to  its  effect  on  steroid  hydroxylation  in 
microsomes from adrenal  cortex (25),  by interac- 
ting  with  the  hemoprotein  called  "CO-binding 
pigment"  (5)  or  "cytochrome  P-450"  (6,  7).  As 
shown in Table II, the effect of CO on drug  hy- 
droxylation  appears  to  be  unique  among  micro- 
somal  TPNH-oxidizing  reactions,  in  that  a  con- 
centration  of  CO  that  blocks  oxidative 
demethylation  of  aminopyrine  completely  is  en- 
tirely without inhibitory effect on the TPNH-cyto- 
chrome c,  -DCPIP,  and -NT reductase  activities 
The  rate  of lipid  peroxidation  was  in  fact  even 
slightly stimulated  by  CO.  As  has  been  reported 
elsewhere (8), drugs undergoing oxidative demeth- 
ylation inhibit lipid peroxidation, which is restored 
by  CO.  Hence,  the stimulating  effect of CO  ob- 
served here might  be due to the suppression  of a 
slow  rate  of  hydroxylation  of  some  endogenous 
substance(s)  possibly present in the microsomes. 
Fig.  5  illustrates the effects of PCMB and  SKF 
525A  on  the  various  TPNH-oxidizing  reactions. 
PCMB inhibited not only oxidative demethylation, 
but  also lipid peroxidation  and  the TPNH-linked 
reduction of NT; but it had little effect on the re- 
duction of DCPIP,  and only slightly inhibited the 
reduction  of cytochrome c.  These effects were in- 
vestigated  without  preincubation  of  the  micro- 
somes with  PCMB  prior  to  assay.  As  noticed  by 
Phillips  and  Langdon  (4),  TPNH-cyt0chrome  c 
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Fig. 4 b, competitive inhibition of oxidative demethylation by TPN. [I], TPN, raM; v, relative reaction 
velocity. 
reductase  does  acquire  a  PCMB  sensitivity  upon 
preincubation.  SKF 525A, a well known inhibitor 
of microsomal  hydroxylations  (see  reference  26), 
exerted  a  partial  inhibition on  both  this  reaction 
and  the peroxidation  of lipids,  but  had  no effect 
on the TPNH~:ytochrome  c,  -NT,  and  -DCPIP 
reductase reactions. 
As first noticed by Gillette et al.  (27),  liver mi- 
erosomes exhibit a  slow rate of TPNH-dependent 
oxygen uptake, with the formation of H~O2, which 
requires no externally added hydrogen or hydroxyl 
acceptor. This "TPNH oxidase" reaction was later 
studied by  Fouts  (28)  in connection with the sub- 
microsomal localization of the drug-hydroxylating 
enzyme system.  As shown in Table III,  this reac- 
tion is entirely insensitive to CO,  and is only par- 
tially inhibited by PCMB, properties which clearly 
distinguish  it  from  drug  hydroxylation.  On  the 
other hand,  the reaction was found to be partially 
inhibited  by DPPD,  DIC,  and  KCN.  Neither of 
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Oxidative  Demethylation  of  Aminopyrine  with 
Various Hydrogen Donors 
The  incubations were carried out as described 
in Materials  and Methods,  but TPN  and  the 
TPNFI-generating system were omitted.  Pyri- 
dine nucleotides and ascorbate were added  in 
final concentrations as  indicated. 
Additions 
Oxidative 
demethylation 
activity 
mt~moles 
FA/min./mg 
protein 
TPNH,  3 m~t  3.40 
DPNH,  1 mM  0.18 
2 mM  0.35 
3  mM  0.49 
4  mM  0.42 
TPNH,  3 mM +  DPNH,  3 mM  3.42 
TPN,  2 m~a  0 
4  mM  0.15 
DPNH,  3 mM  +  TPN, 0.25 mM  1.32 
0.5 mM  1.46 
1  mM  1.45 
2  InM  1.00 
4  m~t  0.50 
Ascorbate, 2 m~  0.10 
4  m~  0.16 
8  mM  0.14 
these agents inhibited the oxidative demethylation 
of aminopyrine. The possible implications of these 
findings will be considered later (see Discussion). 
Studies with Phenobarbital-Treated  Rats 
As already reported  (1),  treatment of rats with 
a  daily  dose  of  100  mg  of phenobarbital  per  kg 
body weight during 5  days leads  to  a  4  to  6-fold 
increase in the oxidative demethylating activity of 
the liver microsomes.  A  parallel  and selective in- 
crease occurred in the amount of CO-binding pig- 
ment  and  the  activity  of  TPNH~ytochrome  c 
reductase.  In the present study it could be estab- 
lished that the affinities of the drug-hydroxylating 
system  and  TPNH-cytochrome  c  reductase  for 
TPNH  were  unchanged  as  compared  with  those 
found  in  the  untreated  animals,  as  was  also  the 
affinity of the drug-hydroxylating system for ami- 
nopyrine.  Likewise unchanged were the K~ values 
for the inhibition by TPN. 
As shown in Table IV, the TPNH-DCPIP  and 
-iWF  reductase  activities of  the  liver  microsomes 
increased upon treatment of rats with phenobarbi- 
tal, in a fashion parallel to the TPNH~ytochrome 
c reductase.  The lipid-peroxldating activity of the 
microsomes  from  phenobarbital-treated  animals 
was  not  investigated,  since  it  might  be  expected 
that the liver microsomes of these  animals would 
contain bound drug which inhibits lipid peroxida- 
tion  (8).  A  drug-induced  increase was  also found 
in  the  TPNH-linked  oxidation  of luminol,  as  re- 
ported  elsewhere  (29).  On  the other  hand,  there 
was no  increase  in  the  drug-hydroxylating  activ- 
TABLE  II 
Effect of Carbon Monoxide on Microsomal TPNH Oxidation 
The incubations were carried out in Warburg vessels, which were filled with the gas mixture, except 
for the recordings of cytochrome c reductase and DCPIP reductase activities, in which the gas mixture 
was bubbled through the cuvette for 20 seconds before the activity was measured. 
Gas phase 
4% 02; 56% 
System  4% 02; 96% N'~  N2; 40% CO 
Cytochrome c reduetase  (m#moles eyt.  c red./min./mg protein) 
NT reductase  (m/~moles NT red./min./mg protein) 
DCPIP  reductase  (m/~moles DCPIP red./min./mg protein) 
Lipid peroxidation  (mNmoles MA formed/min./mg protein) 
Oxidative demethylation  (m/~moles FA formed/min./mg protein) 
60  58 
109  120 
60  56 
4.12  5.40 
3.11"  0.38 
* When air was used as gas phase,  the corresponding value was 3.09. 
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TABLE  III 
Ej~ects of Various Inhibitors on Microsomal TPNH- 
Dependent  Oxygen  Uptake 
TPNH oxidase was recorded in the absence of 
drug  as described in Materials and Methods. 
Oxygen 
Additions  consumption 
mt~moles O~ 
consumed  /min.  / 
mg protein 
TPNH,  10  -4 M  3.28 
TPNH, 3.0 X  10  -4 •  4.02 
TPNH, 6.0 X  10  -4 ~  3.92 
TPNH, 3.0  X  10  -4 M  3.90 
+  40% CO  4.02 
TPNH, 3.0 X  10  -4 ~  4.00 
+  PCMB,  10  -4 M  1.95 
+  PCMB,  10  -a M  1.90 
TPNH, 3.0 X  10  -4 M  4.15 
+  DPPD,  1 #g  4.00 
+  DPPD, 3 /~g  3.40 
+  DPPD, 5 #g  3.41 
TPNH, 3.0  X  10  --4 ~  4.15 
+  DIC, 5.0  X  10  -7 ~  3.02 
+  DIC,  1.5  X  10  -6 ~  2.54 
+  DIC, 3.0  X  10  -6 M  2.52 
TPNH, 3.0  X  10  -4 M  4.10 
+  KCN,  1.2  X  10  -4 ~  3.70 
+  KCN, 2.5  X  10  -4 ~  3.60 
+  KCN, 5.0 X  10- 4 M  3.60 
TPNH,  3.0  X  10  -4 ~  4.03 
+  TPN, 2.0  X  10  -4 ~  3.02 
+  TPN, 4.0 X  10  -4 M  2.50 
ity as measured with DPNH alone or in combina- 
tion with TPN. 
Liver  microsomes from  untreated  animals  re- 
vealed only a  relatively modest difference in oxy- 
TABLE  IV 
Effect of Phenobarbital  Treatment on the Microsomal 
Oxidation  of TPNH  with  Various 
Electron Acceptors 
Measurements were made by following the re- 
duction of the acceptors (16) in the presence of 
10  -6 M dicoumarol. 
No. of  Acceptor 
pheno- 
barbital 
treat- 
ments  Cytochromc  ¢  DCPIP  NT 
umoles TPNH ox./min./mg protein 
0  0.032  0.039  0.100 
3  0.096  0. 145  0. 348 
5  0.130  0. 190  0.420 
gen uptake when incubated with TPNH alone and 
with TPNH plus aminowrine (1); the values usu- 
ally observed were about 2  to 4  m~moles 02 con- 
sumed per minute per mg protein in the absence, 
and 5  to  7  in the presence, of aminopyrine. This 
difference was strikingly increased in  the  pheno- 
barbital-treated animals, owing to  a  selective ac- 
tivation of the drug-induced oxygen uptake. This 
situation provided favorable conditions for deter- 
mining with some  accuracy the stoichiometry of 
the oxidative demethylation reaction with regard 
to  oxygen  consumption,  TPNH  disappearance, 
and formaldehyde formation. Results of a series of 
such  determinations,  summarized  in  Table  V, 
show a  molar relationship near to  I  between ami- 
nopyrine-induced increase in oxygen consumption 
and  TPNH  disappearance,  and  the  amount  of 
formaldehyde formed. 
Many  attempts  have  been  made  to  solubilize 
the  drug-hydroxylating  enzyme  system  of  liver 
microsomes (30).  However, only a  minor part of 
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Stimulation of Microsomal TPNH Oxidation by Aminopyrine 
Exp. no. 
Oxygen consumption  TPNH oxidation*  FA formation 
--AP  +AP  A  --AP  +AP  A  +AP 
mmnoles  /min. / 
m,,moles/min./mg protein  m~mdes/min./mg protein  mg protein 
1  5.3  20.1  14.8  4.9  18.0  13.1  14.0 
2  4.9  21.5  16.6  6.1  20.5  14.4  15.2 
3  4.9  20.8  15.7  6.0  19.5  13.5  15.8 
4  6.0  20.1  14.1  6.2  20.0  13.8  15.0 
5  5.3  16.2  10.9  6.2  15.4  9.2  10.6 
* TPNH oxidation was determined spectrophotometrically by following the change of absorbancy at 340 
m/z. 
TABLE  VI 
Solubilization of the Oxidative Demethylating System by Naja naja Venom Treatment of Microsomes 
Isolated from Phenobarbital-Treated Rats and Controls 
No. of phe- 
nobarbital 
treatments  Fraction  Protein 
GO-binding pigment 
P-450  P-420 
Oxidative de-  TPNH-cyto- 
methylation  chrome ¢ reduc-  Reduced  by  Reduced  by  Reduced  by  Reduced  by 
activity  tase activity  NazS204  TPNH  Na2S~O4  TPNH 
0  Microsomes 
Solubilized 
Pellet 
4  Microsomes 
Solubilized 
Pellet 
mg/gm  m~moles  FA/  I~moles TPNH ox./ 
liver  min./mg protein  min,/mg protein  &E45o_~  oo/mg protein  £xE42o_5  oo/mg protein 
23.1  2.75  0.024  0.020  0.019  --  -- 
11.0  0.68  0.024  --  --  0.019  0.003 
11.3  0.00  0.010  --  --  0.012  0.000 
26.2  11.50  0.090  0.077  0.077  --  -- 
16.0  2.40  0.095  --  --  0.083  0.019 
9.3  0.00  0.017  --  --  0.048  0.000 
the drug-hydroxylating activity has been recovered 
upon  solubilization,  and  further  purification  has 
failed to give a reasonable concentration of the ac- 
tivity on the protein basis. Omura and Sato (6,  7) 
have shown that solubilization of the CO-binding 
pigment  of liver  microsomes by  treatment  with 
heated snake venom or deoxycholate is accompa- 
nied by a  shift of the absorption peak from 450 to 
420 m/z. Whereas the P-450 form is readily reduced 
by TPNH, the P-420 form is only poorly reducible 
enzymatically.  Table  VI  shows the results of at- 
tempts to  solubilize the  oxidative  demethylating 
system  by  treatment  with  heat-treated  snake 
venom, using liver microsomes isolated from both 
normal and phenobarbital-treated rats.  It may be 
seen that, in both cases, the supernatant after sol- 
ubilization exhibited about  the same specific ac- 
tivity of TPNH~cytochrome c reductase as did the 
original  microsomes. Naja  naja venom treatment 
also solubilized the CO-binding pigment and con- 
verted  it  into  the  P-420  form,  which  was  only 
slightly reducible  by  TPNH.  However,  a  minor 
part of the P-420 could be reduced by TPNH, and 
this part was found to be increased by phenobarbi- 
tal  stimulation of the rats in vivo. Parallel to  this, 
an  increased  activity  of aminopyrine demethyla- 
tion was recovered in the supernatant from pheno- 
barbital-stimulated  rats  as  compared  with  the 
controls.  Apparently,  the  decrease  of  the  drug- 
hydroxylating  activity  upon  solubilization  is  re- 
lated to  the modification of the CO-binding pig- 
ment. 
DISCUSSION 
For studying the rates of hydroxylation of various 
drugs by liver microsomes and especially for stud- 
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vivo  treatment with inducing drugs, it is of great 
importance that the activities are  assayed  under 
optimal  conditions. Kinetic studies  presented  in 
this paper establish the quantitative requirements 
for drug and TPNH in obtaining maximal reac- 
tion rates  of oxidative demethylation which  are 
linear with time and with the  amount of micro- 
somal protein. The fact that the Km values for drug 
and TPNH are unchanged in the microsomes from 
the drug-treated animals eliminates the possibility 
that the enhancement  of drug hydroxylation  found 
in these microsomes might be due to an increased 
substrate affinity rather than to a net increase in 
enzyme  content.  Activation of  microsomal  glu- 
cose-6-phosphatase  in  alloxan-diabetic  rats,  re- 
versed by insulin, has earlier been found by Segal 
and Washko  (31)  to  be connected with shifts  in 
the affinity of the enzyme for its substrate. 
Of particular importance in establishing optimal 
conditions for  determination of  the  microsomal 
drug-hydroxylating activity may  be  the  present 
finding that TPN is a competitive inhibitor of the 
process.  Earlier observations that  DPNH  stimu- 
lates  TPNH-linked drug  hydroxylation (32,  33) 
may be explained on the basis of a removal of TPN 
by way of transhydrogenase. In the present experi- 
ments, using conditions preventing TPN accumu- 
lation,  no  stimulation of  the  reaction  rate  by 
DPNH  was  found.  Whether  the  slow  reaction 
driven by DPNH  alone  proceeds  by  a  separate 
pathway or by a trace of TPN bound to the micro- 
somes cannot be decided on the basis of the data 
available. Also the nature of the microsomal trans- 
hydrogenase reaction and its relationship to those 
occurring in mitochondria (34,  35)  will  require 
further  investigation. The  fact  that  the  DPNH 
q-  TPN-driven  drug  hydroxylation  activity  of 
the microsomes does  not increase parallel to  the 
TPNH-driven one upon drug treatment indicates 
that  the  drug-induced  activation  of  the  hy- 
droxylating enzyme system does  not include the 
transhydrogenase. 
A  similar conclusion seems to apply to the mi- 
crosomal "TPNH oxidase" reaction. This reaction 
is unaffected by CO,  a fact which suggests that it 
is not a functional reflection of the entire hydroxyl- 
ating  enzyme  system  including the  cytochrome 
P-450.  The effect  of DPPD  suggests  the involve- 
ment of lipid peroxidation (23,  24),  a  possibility 
also  supported  by the  observation of Staudinger 
and Zubrzycki (36) that the molar ratio of oxygen 
consumed to TPNH oxidized in the TPNH oxidase 
reaction slighdy exceeds  1. Inhibition by low con- 
centration of DIC suggests the involvement in the 
TPN-H oxidase reaction of the enzyme DT diaph- 
orase (37), small amounts of which are consistently 
found in rat  liver microsomes  (38).  By reacting 
with a quinone possibly present in the microsomes, 
and subsequent autooxidation of the reduced qui- 
none, I)T diaphorase might account for a part of 
the TPNH oxidase reaction.  Finally, the  partial 
sensitivity to  KCN  suggests  the  involvement of 
cytochrome oxidase,  possibly present in the form 
of  contaminating traces  of  mitochondrial  frag- 
ments,  although  the  pathway  by  which  TPNH 
would  be oxidized by this  system is  unclear.  In 
any case, the present data warrant caution in using 
TPNH oxidase as  a  parameter in measuring mi- 
crosomal drug hydroxylation. 
By using microsomes isolated from phenobarbi- 
tal-pretreated rats, it has been possible in this work 
to establish the stoichiometry of the oxidative de- 
methylation reaction. This was shown to involve a 
1 : 1 : 1 molar relationship between TPNH oxidized, 
02 consumed, and formaldehyde produced, which 
substantiates the generally proposed equation (see 
reference 26) : 
RCH3 -t- TPNH q- H + -[- 02 
RH -k- HCHO +  TPN  + -b H20 
Studies with various electron acceptors and in- 
hibitors have provided important information con- 
cerning the components of the drug-hydroxylating 
system.  This information is summarized schemat- 
ically in Fig.  6.  Involvement of the flavoprotein 
known as TPNH-cytochrome c reductase and the 
CO-binding pigment called cytochrome P-450 in 
the  hydroxylating system has  been strongly sug- 
gested  by  the  selective  increase in  the  levels  of 
these  two  enzymes parallel  to  the  drug-induced 
increase in the over-all hydroxylating activity (1). 
The involvement of TPNH--cytochrome c reduc- 
tase is further supported by the similar Km values 
for TPNH of the eytochrome c reductase and the 
drug-hydroxylating reaction,  as  well  as  by their 
similar  inhibition by  TPN,  as  revealed  by  the 
present data. The CO-binding  pigment, which was 
first  described  by Klingenberg (5),  has  recently 
been solubilized by Omura and Sato  (6,  7)  and 
shown to be a cytochrome of the b type. The par- 
ticipation of this enzyme in the hydroxytation of 
steroids by adrenal microsomes was first  demon- 
strated  by Estabrook et  al.  (25),  whereas  its  in- 
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crosomes was shown in this laboratory (8) and later 
confirmed by Staudinger et al.  (39). 
The  interaction  between  TPNH-cytochrome  c 
reductase and the CO-binding pigment may prove 
to  be  a  complex process,  as  suggested  by several 
observations.  The  fact  that  PCMB  strongly  and 
consistently inhibits oxidative demethylation while 
it exerts a variable influence--inhibition, no effect, 
or stimulation,  depending on the assay conditions 
--on  the TPNH~ytochrome  c reductase  (4)  sug- 
gests  that  the  flavoenzyme  involves  sulfhydryl 
groups, which are essential for the coupled reaction 
but not for the simple cytochrome c reductase func- 
tion.  The occurrence  of a  NT reductase  activity, 
which is more labile than the cytochrome c reduc- 
tase (3,  16),  and which again is consistently PCMB 
sensitive, further suggests the existence of multiple 
sites or  modes of action  of the flavoprotein.  The 
involvement of additional  electron  transfer  cata- 
lysts in  the  coupled  reactions,  such  as  non-heine 
iron or a quinone, is also a conceivable possibility. 
Finally,  the  question  as  to  whether  the  drug- 
hydroxylating system involves specific enzymes for 
the  activation  of the  individual  drugs  cannot  be 
answered on the basis of the information presented 
in this paper.  Data from experiments with various 
inducing drugs are presented in a succeeding paper. 
(40)  and discussed in relation to this problem. 
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CO 
PCMBI  [  /RCH3  +O2 
TPNH --~ Fp  [  ......... ? .........  ~ P - 450 
|  ~  ~  ]  "~RH  +  HCHO  cyt. c  NT  FePP 
/  \ 
lip.  +  O~  lip., 02 
MA 
~Gm~E 6  tIypothetie  reaction  pathways  of mierosomal drug  hydroxylation  and  related  reaetions.  Fp 
flavoprotein. 
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